In Germany, healthcare is very important. Health goods include everything that keeps us healthy and are a central part of our healthcare system.
The healthcare industry is enormous: in 2023, its value creation reached €435.5 billion, accounting for nearly 11.5 percent of Germany’s GDP. Over 15 percent of the workforce is employed in this sector.
Medical services make up a large part of health goods, including outpatient and inpatient treatments, medications, medical aids, and preventive measures. Funding comes from health insurance, taxes, and out-of-pocket payments.
Patient care is at the core. In 2022, healthcare spending reached around €498 billion, highlighting the importance of health goods.
Health goods play an essential role in the German healthcare market and differ from conventional economic goods. They are critical to healthcare economics.
Health goods are products and services that protect and promote our health, including medications, medical devices, and medical treatments. They are often considered public goods, as they should be accessible to all.
Health goods are subject to strict regulations, and their demand is unpredictable and often associated with external effects. The German health market is highly innovative: in 2023, Germany exported health products worth over €159.4 billion, accounting for 8.1 percent of total exports.
Health goods are essential for population health and are provided through a system of statutory and private health insurance. In 2020, disease-related costs in Germany amounted to €431.8 billion, or €5,190 per capita. Germany ranks second worldwide in healthcare spending, surpassed only by the USA.
Health goods have unique characteristics that often lead to market inefficiencies. A major issue is externalities, or impacts on third parties not included in the price.
In the case of vaccinations, not only does the vaccinated person benefit, but society as a whole also gains. This underscores the importance of considering these effects.
The Coase Theorem suggests that private negotiations can be efficient. However, in the healthcare sector, challenges such as high transaction costs and information asymmetry between patients and professionals make this difficult.
Therefore, many see the need for government intervention, such as mandatory insurance and price regulations, to ensure fair distribution and optimal care.
The discussion about efficiency in healthcare is complex, as it balances cost savings and quality. This tension between market and state shapes healthcare policy in Germany.
Germany offers a wide range of high-quality healthcare services. At the end of 2022, there were nearly 421,300 practicing physicians, with 217,400 working in hospitals and 165,700 in outpatient care.
Patients can be treated on an outpatient or inpatient basis. Outpatient services are provided by doctors and therapists, while hospitals handle more complex cases.
Germany has a physician density of 4.45 doctors per 1,000 people, above the OECD average of 3.7.
Prevention is an essential part of the German healthcare system. Research projects like "Ausbau OnlineFoBi FBREK" are developing new training concepts to address health policy issues and improve prevention.
Intensive research drives medical advancement. Projects like the ME/CFS Registry with Biobank seek new therapies, and departmental research helps the healthcare system tackle challenges such as demographic change and digitalization.
Innovative methods like Raman spectroscopy improve the quality control of medications.
In Germany, there are several ways to finance healthcare services. In 2008, statutory health insurance spent €162 billion on health, with costs rising due to an aging population and medical innovations.
The GKV is the backbone of the German healthcare system, covering about 70 million people. Contributions are income-based, with all insured receiving equal rights.
The GKV faces major challenges, as a shrinking workforce impacts financial sustainability.
The PKV covers around 8.6 million people and often attracts wealthier and healthier individuals, which can affect the statutory system.
The PKV offers individualized services, making certain health goods more accessible.
Supplementary and self-pay services are becoming more popular, providing access to services not included in the standard catalog. In 2023, Germany’s healthcare industry exported over €159.4 billion worth of products.
The pharmaceutical industry invests heavily in innovation, which improves health goods over the long term.
Health goods are products and services that support our health, including medical treatments, medications, and medical aids. Preventive measures are also included.
Health goods have unique characteristics. They can be public goods, like vaccinations, and their demand is often unpredictable. Thus, there are specific regulations and market mechanisms.
Market failure in health goods arises from external effects and the nature of public goods. Information asymmetry and high transaction costs can also lead to inefficiencies.
There are outpatient and inpatient treatments as well as preventive measures and research. Outpatient services are provided by doctors and therapists, while hospitals offer inpatient care.
In Germany, health goods are mainly financed by the GKV and PKV. There are also self-pay services and supplementary insurance options.
The GKV is based on solidarity and provides a fixed catalog of services, while the PKV offers individualized services based on the equivalence principle.
Research improves diagnostics and therapies, is vital for patient care, and drives innovation.
Preventive measures help prevent diseases, including vaccinations and screenings. They are essential for health and can save costs in the long term.
Sanofeld is an innovative healthcare agency with a focus on pharma and healthcare. We offer comprehensive marketing services for OTC and RX.
E-Mail: [email protected]
Meeting: 15 Minutes Meeting